Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Increase (Decrease) in Inventories

Insight Molecular Diagnostics Inc. (IMDX) reported Increase (Decrease) in Inventories of -$239.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-10

  • Insight Molecular Diagnostics Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$175.00K, a 174.79% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$64.00K, a 230.61% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$25.00K, a 114.04% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$222.00K, a 195.69% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in inventories for fiscal 2025 was $36.00K, a 91.22% decline from fiscal 2024.
  • Insight Molecular Diagnostics Inc. increase (decrease) in inventories for fiscal 2024 was $410.00K.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2026-06-30-$175.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$239.00K
10-Q · filed 2026-08-10
-$264.00K
derived: sum of 3 quarters · filed 2026-08-10
-$486.00K
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$64.00K
10-Q · filed 2026-05-13
-$89.00K
derived: sum of 2 quarters · filed 2026-05-13
-$311.00K
derived: sum of 3 quarters · filed 2026-05-13
-$77.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
-$247.00K
derived: sum of 2 quarters · filed 2026-03-26
-$13.00K
derived: sum of 3 quarters · filed 2026-08-10
$36.00K
10-K · filed 2026-03-26
2025-09-30-$222.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$12.00K
derived: sum of 2 quarters · filed 2026-08-10
$61.00K
10-Q · filed 2025-11-10
$239.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$234.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$283.00K
10-Q · filed 2026-08-10
$461.00K
derived: sum of 3 quarters · filed 2026-08-10
$693.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$49.00K
10-Q · filed 2026-05-13
$227.00K
derived: sum of 2 quarters · filed 2026-05-13
$459.00K
derived: sum of 3 quarters · filed 2026-05-13
$459.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$178.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$410.00K
derived: sum of 2 quarters · filed 2026-03-26
$410.00K
derived: sum of 3 quarters · filed 2026-03-26
$410.00K
10-K · filed 2026-03-26
2024-09-30$232.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$232.00K
derived: sum of 2 quarters · filed 2025-11-10
$232.00K
10-Q · filed 2025-11-10
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$0.00
10-Q · filed 2025-08-11
2024-03-31$0.00
10-Q · filed 2025-05-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92